Seroepidemiology of hepatitis A in Mexico. A detector of social inequity and monitor of immunization policies;Seroepidemiología de la hepatitis A en México. Sensor de inequidad social e indicadorde políticas de vacunación

Salud Publica de Mexico

Volumn 49, Issue SUPPL. 3, 2007, Pages

  Valdespino, José Luis ^a,b,d   Ruiz Gómez, Juan ^a   Olaiz Fernández, Gustavo ^c   Arias Toledo, Eloísa ^a   Conde González, Carlos J ^a   Palma, Oswaldo ^a   Sepúlveda, Jaime ^a  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b Laboratorio de Biológicos Y Reactivos de México Birmex   (Mexico)

^c SECRETARÍA DE SALUD   (Mexico)

^d Desarrollo Y Aseguramiento de la Calidad IDyAC   (Mexico)

Author keywords

Inequity; Mexico; Seroepidemiology; Viral hepatitis A

Indexed keywords

EID: 34548066841     PISSN: 00363634     EISSN: 16067916     Source Type: Journal    
DOI: 10.1590/s0036-36342007000900009     Document Type: Article

References (17)

1. Cuthbert JA. Hepatitis A: old and new. Clin Microbiol Rev 2001;14(1):38-58.
2. Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1999;48(RR-12):1-37.
3. Costa-Mattioli M, Cristina J, Romero H, et al. Molecular evolution of hepatitis A virus: a new classification based on the complete VP1 protein. J Virol 2002;76(18):9516-9525.
4. Jong EC. United States epidemiology of hepatitis A: influenced by immigrants visiting friends and relatives in Mexico? Am J Med 2005;118(Suppl 10A):S50-S57.
5. Doyle TJ, Bryan RT. Infectious disease morbidity in the US region bordering Mexico, 1990-1998. J Infect Dis 2000;182(5):1503-1510.
6. Webster G, Barnes E, Dusheiko G, et al. Protecting travellers from hepatitis A. BMJ 2001;322(7296):1194-1195.
7. Mutsch M, Spicher VM, Gut C, et al. Hepatitis A virus infections in travelers, 1988-2004. Clin Infect Dis 2006;42(4):490-497.
8. Shapiro CN, Coleman PJ, McQuillan GM, et al. Epidemiology of hepatitis A: seroepidemiology and risk groups in the USA. Vaccine 1992;10(Suppl 1):S59-S62.
9. Wheeler C, Vogt TM, Armstrong GL, et al. An outbreak of hepatitis A associated with green onions. N Engl J Med 2005;353(9):890-897.
10. Notice to Readers: FDA Approval of Havrix® (Hepatitis A Vaccine, Inactivated) for Persons Aged 1-18 Years. MMWR Morb Mortal Wkly Rep 2005;54(48):1235-1236.
11. Notice To Readers: FDA Approval of VAQTA® (Hepatitis A Vaccine, Inactivated) for Children Aged >1 Year. MMWR Morb Mortal Wkly Rep 2005;54(40):1026.
12. Kershenobich D. Hepatitis A: is universal vaccination justified in Mexico? Rev Gastroenterol Mex 1996;61(4 Suppl 2):S69-S70.
13. Mazari-Hiriart M, López-Vidal Y, Ponce-de-Leon S, et al. Longitudinal study of microbial diversity and seasonality in the Mexico City metropolitan area water supply system. Appl Environ Microbiol 2005;71(9):5129-5137.
14. Kumate J, Alvizouri AM, Isibasi A. Serologic survey of hepatitis A antibodies in Mexican children. Bull Pan Am Health Organ 1982;16(2):156-160.
15. Ruiz-Gómez J, Bustamante-Calvillo ME. Hepatitis A antibodies: prevalence and persistence in a group of Mexican children. Am J Epidemiol 1985;121(1):116-119.
16. Bustamante-Calvillo ME, Velázquez-Castillo FR, Padilla-Noriega L, et al. Seroepidemiology of hepatitis A virus infection in communities of the southern border of the State of Chiapas. Bol Med Hosp Infant Mex 1986;43(12):735-741.
17. Tapia-Conyer R, Santos JI, Cavalcanti AM, et al. Hepatitis A in Latin America: a changing epidemiologic pattern. Am J Trop Med Hyg 1999;61(5):825-829.